CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

• Auteurs principaux: Sychev DA (Auteur), Baturina OA (Auteur), Mirzaev KB (Auteur), Rytkin E (Auteur), Ivashchenko DV (Auteur), Andreev DA (Auteur), Ryzhikova KA (Auteur), Grishina EA (Auteur), Bochkov PO (Auteur), Shevchenko RV (Auteur)
• Format: Livre
• Publié: Dove Medical Press, 2020-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

DA Sychev,1 OA Baturina,2 KB Mirzaev,1 E Rytkin,1 DV Ivashchenko,1 DA Andreev,2 KA Ryzhikova,1 EA Grishina,1 PO Bochkov,1 RV Shevchenko1 1Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Moscow, Russian Federation; 2Sechenov University, Mosc...